AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Roche’s breast cancer drug patent partly annulled by Indian government

 cancer, Uncategorized  Comments Off on Roche’s breast cancer drug patent partly annulled by Indian government
Aug 062013
 

 

Roche’s breast cancer drug patent partly annulled by Indian government
Patents granted to pharmaceutical giant Roche Holding for the breast cancer drug Herceptin (trastuzumab) have been partially voided by the Indian government.

read all at

http://www.pharmaceutical-technology.com/news/newsroches-breast-cancer-drug-patent-partly-annulled-by-indian-government?WT.mc_id=DN_News

and

http://newdrugapprovals.wordpress.com/2013/02/23/fda-approves-kadcyla-ado-trastuzumab-emtansine-a-new-therapy-for-patients-with-her2-positive-late-stage-metastatic-breast-cancer/

Share

New Compound May Be Future Of Breast Cancer Treatment

 cancer  Comments Off on New Compound May Be Future Of Breast Cancer Treatment
Jul 142013
 
Image Credit: Photos.com

Rebekah Eliason for redOrbit.com – Your Universe Online

Scientists from Melbourne, Australia recently discovered compounds currently being researched to treat leukemia may also be effective in treating the most common form of breast cancer.

Researchers found a group of anti-cancer compounds known as BH3-mimetics are effective for treating estrogen receptor-positive (ER-positive) forms of breast cancers when used with tamoxifen, a drug currently used to treat breast cancer. Breast cancer is comprised of roughly 70 percent ER-positive types.

http://www.redorbit.com/news/health/1112893311/compound-bh3-mimetics-future-of-breast-cancer-treatment-070913/

 

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: